ENTITY
Chongqing Zhifei Biological Products

Chongqing Zhifei Biological Products (300122 CH)

130
Analysis
Health Care • China
Chongqing Zhifei Biological Products Company Ltd. researches, manufactures, and sells vaccines and biological products including prevention products, blood products, diagnostic reagents, and therapeutic agents.
more
•31 Aug 2026 19:53

MS-China Sep 2026 Index Rebalance: Pre-Implementation Update

MS-China enters implementation on 1 Sep with 33 ADDs and 32 DELETEs. We update post-announcement stock performance and discuss implementation trades.

Logo
99 Views
Share
•21 Aug 2026 09:22

CanSino Biologics(6185 HK): Price Surged - Worth a Shot !!

CanSino Biologics (6185 HK)  shares surged on the back of Moderna (MRNA US)  breakthroughs with its mRNA vaccine for melanoma. Cansino was China's...

Logo
167 Views
Share
•06 Jul 2023 08:55

2023H2 China Healthcare Investment Strategy and Top Pick

There're structural opportunity in China healthcare in 23H2. We advise investors not to miss out.Risks remain, offloading after rebound is...

Logo
825 Views
Share
•10 Aug 2026 14:43

MS-China Sep 2026 Index Rebalance Forecast

We forecast 16 ADD candidates and 22 DELETE candidates for the MS-China August 2026 Quarterly Index Review, with the announcement expected after US...

Logo
133 Views
Share
•03 Aug 2026 14:30

MS-China Index Earning Revision (Jul): TENCENT, MAXSCEND MICROELECTRONICS, MEITUAN, XIAOMI, JD.COM

We analyzed MS-China's consensus for Jul 2026 and highlighted changes of EPS in TENCENT, MAXSCEND MICROELECTRONICS, MEITUAN, XIAOMI, JD.COM,...

Logo
178 Views
Share
x